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Primary hyperparathyroidism is perhaps the most common def-
inite disease causing calcium stone formation being present in
up 5-10% of calcium renal stone formers.
The enlargement of a single gland with the characteristic of an
adenoma or the hyperplasia of all four glands cause excessive
secretion of parathyroid hormone which produces hypercal-
cemia and consequently hypercalciuria because of the in-
creased filtered load of calcium. Hypercalciuria and increased
phosphate excretion tend to promote calcium stone formation
by raising the urinary calcium phosphate activity product.
Clinical diagnosis of hyperparathyroidism begins with docu-
menting persistently elevated level of serum calcium, but in
some cases the elevation may be small.
We describe a patient with recurrent renal stone formation pre-
senting with hypercalciuria and serum calcium at the upper lim-
it of the normal range who refused neck exploration and there-
after was followed up for 20 years.
Case report
A 54-year-old women was admitted to our institution in October
1983 with an history of left lumbar pain.
Medical history revealed previous spontaneous passage of 11
urinary calcium stones during the preceding 27 years without
known biochemical or hormonal abnormalities. The age at
stone onset was 27 year, the time to recurrence after the first
renal stone was 3 year.
Intravenous pielography (IVP) showed a 1 cm radiopaque
stone of the left pelvic junction with hydronephrosis and the pa-
tient underwent surgical pyelolithotomy.
One month after stone removal a blood sample was taken and
a 24 h urine urine sample was collected for determination of
potassium, sodium, calcium, phosphate, urate, oxalate and
creatinine (Table I). Urinary volume and pH were recorded and
urinary oxalate was measured in the urine. An oral calcium
load test was performed as follow. A serum sample was taken
and urine was collected on fasting from 7 A.M. to 9 A.M. An
oral load of 1 gr of calcium was then given as calcium lactoglu-
conate and calcium carbonate.Urine was collected from 9 A.M.
to 1 P.M. with a serum sample taken at 1 P.M. Calcium,inor-
ganic phosphate and creatinine were measured on each serum
and urine sample.Urinary calcium excretion was expressed as
calcium to creatinine ratio. Fasting and after load serum con-
centrations of calcium were respectively 9.9 and 10.8 mg/dl,
while fasting and after load calcium to creatinine ratio were re-
spectively 0.05 and 0.21 suggesting the diagnosis of absorp-
tive hypercalciuria.
Serum PTH was in the normal range, sonography and scintig-
raphy of parathyroid were not able to show any enlargement of
parathyroid glands. 
On this basis we deferred neck exploration and placed the patient
on thiazides treatment in order to “unmask” a latent hyperparathy-
roidism, but unfortunately the patient was lost at follow up.
After some years we recalled systematically our patients in or-
der to obtain information on stone recurrence.The patient
replied to our invitation and she presented for a follow up visit
(Tables II and III).
She had developed hypertension being on treatment with
propanolol and she had been treated for pancreatitis owing to
persistently elevated levels of serum amylase whereas stone
disease had not recurred.The serum level of parathyroid hor-
mone was now in the upper range of normal values but scintig-
raphy was still negative for parathyroid enlargement.
Thereafter blood and 24 urine determinations were repeated
every 6 months till now.
Since November 1999, progressively elevated parathyroid hor-
mone levels were shown, ranging between 208 and 501 ng/ml.
On September 2002 an aortic aneurysm involving the celiac
trunk was diagnosed.
The patient refused any further surgical treatment.
Actually she is on treatment with propanolol (40 mg) and
ramipril (5 mg).
A recent measurement of bone density at femur neck and lum-
bar spine showed a marked decrease of mineral content.
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Table I - Serum levels and urinary risk factors for stone disease at
first visit.
Serum Urine 24-h Urine
K mEq/L mEq/l 21
Na mEq/L mEq/L 95
Ca mg/dl 10.1 mg/dl 12.6 CaT mg/day 226
PO4 mg/dl 2.4 mg/dl 21 PO4T mg/day 378
UA mg/dl mg/dl 34 UAT mg/day 612
Cr mg/dl 1.4 mg/dl 80
Ox mg/dl 2.2 OxT mg/day 39.6*
Vol ml 1800 Ca/Cr 0.157
pH 5.5
* Colorimetric Hodgkinson-Williams method.
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Table II - Serum levels in the follow up visits
7/3/94 3/10/94 10/4/95 6/11/95 13/5/96
K mEq/L 3.8 3.9 3.8 4.1 4.0
Na mEq/L 147 145 146 145 141
Ca mg/dl 9.96 10.0 9.80 10.2 10.9
PO4 mg/dl 1.9 2.3 2.2 2.0 2.6
UA mg/dl 3.4 4.4 5.7 4.7 6.0
Cr mg/dl 0.83 0.92 1.0 1.0 1.18
16/12/97 15/6/98 Nov 2000 Apr 2001 May 2003
K mEq/L 4.1 4.0
Na mEq/L 141 142
Ca mg/dl 11.0 11.0 12.39 11.83 11.48
PO4 mg/dl 2.78 2.40
UA mg/dl 6.0 7.0
Cr mg/dl 1.1 0.8
Table III - Urinary risk factors for stone disease in the follow up visits.
7/3/94 3/10/94 10/4/95 6/11/95 13/5/96
Vol ml 1150 1550 750 1450 1650
PH 5.6 6.4 5.6 6.7 6.0
K mEq/L 29 29 41 31 26
Na mEq/L 76 81 86 70 90
Ca mg/dl 12.5 13.3 5.8 3.36 2.0
PO4 mg/dl 32 31 53 25 25
UA mg/dl 32 17 39 16 14
Ox mg/dl 1.55 1.7 4.1 1.3 1.17
Cit mg/dl 2.07 0.46 4.7 10.8 5.3
Mg mg/dl 4.81 6.3 7.47 4.51 4.81
Cr mg/dl 57 40 83 34.5 40
CaT mg/day 143 206 43 48 33
PO4T mg/day 368 480 397 362 412
UAT mg/day 368 263 292 232 231
OxT mg/day 17.8 26.3 30.7 18.8 19.3
CitT mg/day 23.8 7.1 35.2 156 87
MgT mg/day 55 97 55 65 79
16/12/97 15/6/98
Vol ml 1300 1400
PH 5.8 5.8
K mEq/L 31 33
Na mEq/L 77 108
Ca mg/dl 2.2 2.3
PO4 mg/dl 32.8 24.8
UA mg/dl 16 23
Ox mg/dl 1.28 1.82
Cit mg/dl 3.68 9.0
Mg mg/dl 6.2
Cr mg/dl 46 50
CaT mg/day 28 32
PO4T mg/day 426 347
UAT mg/day 208 322
OxT mg/day 16.6 25,4
CitT mg/day 48 126
MgT mg/day 80
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Discussion
PTH stimulates renal tubular calcium reabsorption (1), there-
fore is difficult to explain how an exaggerated secretion of PTH
could lead to hypercalciuria with normal serum calcium values
(normocalcemic hyperparathyroidism).
On the contrary this finding could be explained as a conse-
quence of a primitive tendency to renal calcium leak with sec-
ondary elevation of parathyroid secretion and anatomical hy-
perplasia of the parathyroid glands (secondary hyperparathy-
roidism).
An alternative explanation for the existence of normocalcemic
hyperparathyroidism is that phosphate depletion provoked by
elevated PTH may cause a reduction of renal calcium reab-
sorption before the increase of serum calcium (2).
In the present patient we demonstrated the progressive
change of the biochemical and clinical presentation from a re-
nal disease characterized by hypercalciuria and recurrent cal-
cium stone formation to a bone disease with low urinary ex-
cretion of calcium and progressively higher calcium and PTH
l e v e l s .
Probably this change has been enhanced from the “unmask-
ing” effect by thiazide administration (3,4) and from the effect
on calcium metabolism of estrogenic deprivation after
menopause. In this case the normal values of PTH in the early
period of observation can be explained by the problem con-
nected with the routine determination of serum PTH in the ear-
ly eighties. In fact N-terminal assay was often not able to dis-
close elevated levels of PTH in mild primary hyperparathy-
roidism. 
Unfortunately we were not able to evaluate citrate excretion at
the first observation, although the acidic value of urine on fast-
ing should be enough to exclude a pre-existent renal tubular
acidosis.
On the other hand the low citrate excretion observed in hyper-
parathyroid patients have been attributed to a depressed bicar-
bonate reclamation due to chronic phosphate depletion rather
than to a direct effect of parathyroid hormone (5,6).
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